# HYLENEX RECOMBINANT
> **BLA021859** · Biologics License Application · Sponsor: HALOZYME THERAP · Approved 2005-12-02
## Drug
- **FDA Application Number:** BLA021859
- **Application type:** Biologics License Application
- **Brand name:** HYLENEX RECOMBINANT
- **Generic name:** HYALURONIDASE
- **Active ingredients:** HYALURONIDASE RECOMBINANT HUMAN
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** HALOZYME THERAP
- **Manufacturer:** Antares Pharma, Inc.
- **First approval:** 2005-12-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021859)
---
*AI Analytics · CC0 1.0*